Hemostatic Hold-Up: A Rare Case of Endoscopic Retention After Hemostatic Powder Application

止血剂滞留:止血粉应用后内镜下药物滞留的罕见病例

阅读:1

Abstract

Hemospray (TC-325), a powder-based hemostatic spray, is increasingly used for upper gastrointestinal bleeding but can rarely cause endoscope retention. A 74-year-old woman with chronic kidney disease, atrial fibrillation on warfarin, mechanical heart valves, and prior gastric ulcers presented with melena and large-volume hematemesis causing hemodynamic instability. Laboratory findings revealed hemoglobin 7.3 g/dL and international normalized ratio 7. Esophagogastroduodenoscopy showed multiple bleeding arteriovenous malformations in the cardia and fundus, treated with a synthetic self-assembling peptide gel and subsequently with hemospray applied in retroflexion. Withdrawal of the endoscope was initially unsuccessful due to powder adhesion, but aggressive water irrigation enabled removal after 90 minutes. The patient stabilized with transfusions and octreotide, with no recurrent bleeding. This case underscores the risk of endoscope retention when Hemospray is applied retroflexed and suggests aggressive irrigation as a potential remedy. Further studies are needed to optimize Hemospray dosing and evaluate self-assembling peptide-powder interactions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。